Weight-loss drugs like Wegovy and Mounjaro may help tackle obesity while boosting the economy, but NHS services face overwhelming demand.
Accessibility to weight-loss treatments is constrained by NHS resource limitations and prerequisites for patients.
Clinical effectiveness of drugs suggests significant weight loss potential, stressing the importance of lifestyle changes alongside medication.